Wyszukiwarka
Serotonergic–Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms
Abstrakt
Recent studies revealed that the activation of serotonergic 5-HT1A and muscarinic M1, M4, or M5 receptors prevent MK-801-induced cognitive impairments in animal models. In the present study, the effectiveness of the simultaneous activation of 5-HT1A and muscarinic receptors at preventing MK-801-induced cognitive deficits in novel object recognition (NOR) or Y-maze tests was investigated. Activators of 5-HT1A (F15599), M1 (VU0357017), M4 (VU0152100), or M5 (VU0238429) receptors administered at top doses for seven days reversed MK-801-induced deficits in the NOR test, similar to the simultaneous administration of subeffective doses of F15599 (0.05 mg/kg) with VU0357017 (0.15 mg/kg), VU0152100 (0.05 mg/kg), or VU0238429 (1 mg/kg). The compounds did not prevent the MK-801-induced impairment when administered acutely. Their activity was less evident in the Y-maze. Pharmacokinetic studies revealed high brain penetration of F15599 (brain/plasma ratio 620%), which was detected in the frontal cortex (FC) up to 2 h after administration. Decreases in the brain penetration properties of the compounds were observed after acute administration of the combinations, which might have influenced behavioral responses. This negative effect on brain penetration was not observed when the compounds were administered repeatedly. Based on our results, prolonged administration of a 5-HT1A activator with muscarinic receptor ligands may be effective at reversing cognitive decline related to schizophrenia, and the FC may play a critical role in this interaction.
Cytowania
-
8
CrossRef
-
0
Web of Science
-
8
Scopus
Autorzy (5)
-
Paulina Cieślik
-
Adrianna Radulska
-
Grzegorz Burnat
-
Joanna M. Wierońska
Cytuj jako
Pełna treść
- Wersja publikacji
- Accepted albo Published Version
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.3390/ijms22168612
- Licencja
-
otwiera się w nowej karcie
Słowa kluczowe
Informacje szczegółowe
- Kategoria:
- Publikacja w czasopiśmie
- Typ:
- artykuły w czasopismach
- Opublikowano w:
-
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
nr 22,
ISSN: 1661-6596 - Język:
- angielski
- Rok wydania:
- 2021
- Opis bibliograficzny:
- Cieślik P., Radulska A., Burnat G., Kalinowski L., Wierońska J. M.: Serotonergic–Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms// INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES -Vol. 22,iss. 16 (2021), s.8612-
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.3390/ijms22168612
- Weryfikacja:
- Politechnika Gdańska
wyświetlono 106 razy
Publikacje, które mogą cię zainteresować
Procognitive activity of nitric oxide inhibitors and donors in animal models
- P. Cieślik,
- L. Kalinowski,
- J. M. Wierońska
The impact of mGlu2 or mGlu5 receptor activators on the production of l-arginine derivatives and the expression of PRMT5 or DDAH1 enzymes in animal models of cognitive decline
- A. Płoska,
- A. Radulska,
- A. Siekierzycka
- + 5 autorów
The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO• Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice
- A. Płoska,
- A. Siekierzycka,
- P. Cieślik
- + 3 autorów